The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Risks of Primary Extracolonic Cancers Following Colorectal Cancer in Lynch Syndrome
Open accessAbstract
BACKGROUND: Lynch syndrome is a highly penetrant cancer predisposition syndrome caused by germline mutations in DNA mismatch repair (MMR) genes. We estimated the risks of primary cancers other than colorectal cancer following a diagnosis of colorectal cancer in mutation carriers. METHODS: We obtained data from the Colon Cancer Family Registry for 764 carriers of an MMR gene mutation (316 MLH1, 357 MSH2, 49 MSH6, and 42 PMS2), who had a previous diagnosis of colorectal cancer. The Kaplan-Meier method was used to estimate their cumulative risk of cancers 10 and 20 years after colorectal cancer. We estimated the age-, sex-, country- and calendar period-specific standardized incidence ratios (SIRs) of cancers following colorectal cancer, compared with the general population. RESULTS: Following colorectal cancer, carriers of MMR gene mutations had the following 10-year risk of cancers in other organs: kidney, renal pelvis, ureter, and bladder (2%, 95% confidence interval [CI] = 1% to 3%); small intestine, stomach, and hepatobiliary tract (1%, 95% CI = 0.2% to 2%); prostate (3%, 95% CI = 1% to 5%); endometrium (12%, 95% CI = 8% to 17%); breast (2%, 95% CI = 1% to 4%); and ovary (1%, 95% CI = 0% to 2%). They were at elevated risk compared with the general population: cancers of the kidney, renal pelvis, and ureter (SIR = 12.54, 95% CI = 7.97 to 17.94), urinary bladder (SIR = 7.22, 95% CI = 4.08 to 10.99), small intestine (SIR = 72.68, 95% CI = 39.95 to 111.29), stomach (SIR = 5.65, 95% CI = 2.32 to 9.69), and hepatobiliary tract (SIR = 5.94, 95% CI = 1.81 to 10.94) for both sexes; cancer of the prostate (SIR = 2.05, 95% CI = 1.23 to 3.01), endometrium (SIR = 40.23, 95% CI = 27.91 to 56.06), breast (SIR = 1.76, 95% CI = 1.07 to 2.59), and ovary (SIR = 4.19, 95% CI = 1.28 to 7.97). CONCLUSION: Carriers of MMR gene mutations who have already had a colorectal cancer are at increased risk of a greater range of cancers than the recognized spectrum of Lynch syndrome cancers, including breast and prostate cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Self-citationLynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome
Aarnio, M., Mecklin, J., Aaltonen, L. A., Nyström‐Lahti, M., & Järvinen, H. J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640613 · Cited by 599
The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations
Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J. D., Lindblom, A., Lagerstedt, K., Thibodeau, S. N., Lindor, N. M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.026 · Cited by 550
Self-citationRisk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000.
Curtis, R. E., Freedman, D. M., Ron, E., Ries, L. A. G., Hacker, D. G., Edwards, B. K., Tucker, M., & Fraumeni, J. F. (2006) · Cited by 527
Collaborators, T. U., Kote-Jarai, Z., Leongamornlert, D., Saunders, E., Tymrakiewicz, M., Castro, E., Mahmud, N., Guy, M., Edwards, S., O'Brien, L., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.383 · Cited by 399
Newcomb, P. A., Baron, J., Cotterchio, M., Gallinger, S., Grove, J., Haile, R., Hall, D., Hopper, J. L., Jass, J., Le Marchand, L., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0648 · Cited by 389
Self-citationPrediction of Germline Mutations and Cancer Risk in the Lynch Syndrome
Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., Watson, P., Gruber, S. B., Euhus, D., Kinzler, K. W., et al. (2006) · JAMA · doi:10.1001/jama.296.12.1479 · Cited by 384
Self-citationRisks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Baglietto, L., Lindor, N. M., Dowty, J. G., White, D. M., Wagner, A., Gomez Garcia, E. B., Vriends, A. H. J. T., Dutch Lynch Syndrome Study Group, Cartwright, N. R., Barnetson, R. A., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp473 · Cited by 376
Self-citationTravis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj001 · Cited by 342
Win, A. K., Young, J. P., Lindor, N. M., Tucker, K. M., Ahnen, D. J., Young, G. P., Buchanan, D. D., Clendenning, M., Giles, G. G., Winship, I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5590 · Cited by 333
Self-citationThe epidemiology of cancer of the small bowel.
Neugut, A. I., Jacobson, J. S., Suh, S., Mukherjee, R., & Arber, N. (1998) · PubMed · Cited by 310
The Epidemiology of Second Primary Cancers
Travis, L. B. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0414 · Cited by 290
Parry, S., Win, A. K., Parry, B., Macrae, F. A., Gurrin, L. C., Church, J. M., Baron, J. A., Giles, G. G., Leggett, B. A., Winship, I., et al. (2011) · Gut · doi:10.1136/gut.2010.228056 · Cited by 285
Self-citationMultiple Cancer Prevalence: A Growing Challenge in Long-term Survivorship
Mariotto, A. B., Rowland, J. H., Ries, L. A. G., Scoppa, S., & Feuer, E. J. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0782 · Cited by 283
Quehenberger, F., Vasen, H. F. A., & van Houwelingen, H. C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024299 · Cited by 279
HNPCC-associated small bowel cancer: Clinical and molecular characteristics
Schulmann, K., Brasch, F. E., Kunstmann, E., Engel, C., Pagenstecher, C., Vogelsang, H., Krüger, S., Vogel, T., Knaebel, H.-P., Rüschoff, J., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.051 · Cited by 197
Cancer incidence in five continents, vol. VI
Levi, F. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90227-7 · Cited by 197
van der Post, R. S., Kiemeney, L. A., Ligtenberg, M. J. L., Witjes, J. A., Hulsbergen-van de Kaa, C. A., Bodmer, D., Schaap, L., Kets, C. M., van Krieken, J. H. J. M., & Hoogerbrugge, N. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.076992 · Cited by 197
Cancer survivorship--United States, 1971-2001.
(2004) · PubMed · Cited by 191
Jenkins, M. A., Baglietto, L., Dowty, J. G., Van Vliet, C. M., Smith, L., Mead, L. J., Macrae, F. A., St. John, D. J. B., Jass, J. R., Giles, G. G., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.01.002 · Cited by 171
Self-citationHereditary non-polyposis colorectal cancer: The rise and fall of a confusing term
Jass, J. R. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i31.4943 · Cited by 148
Risinger, J. I., Barrett, J. C., Watson, P., Lynch, H. T., & Boyd, J. A. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960501)77:9<1836::aid-cncr12>3.0.co;2-0 · Cited by 141
The risk of subsequent primary cancers after colorectal cancer in southeast England
Evans, H. S., Møller, H., Robinson, D., Lewis, C. M., Bell, C. M. J., & Hodgson, S. V. (2002) · Gut · doi:10.1136/gut.50.5.647 · Cited by 117
Walsh, M. D., Buchanan, D. D., Cummings, M. C., Pearson, S., Arnold, S. T., Clendenning, M., Walters, R., McKeone, D., Spurdle, A. B., Hopper, J. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3058 · Cited by 114
Self-citationGerm-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer
Grindedal, E. M., Møller, P., Eeles, R. A., Stormorken, A. T., Lothe, I. M. B., Landrø, S. M., Clark, N., Kvåle, R., Shanley, S., & Mæhle, L. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0058 · Cited by 113
The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study
Youlden, D. R., & Baade, P. D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-83 · Cited by 102
Enblad, P., Adami, H., Glimelius, B., Krusemo, U. B., & Påhlman, L. (1990) · Cancer · doi:10.1002/1097-0142(19900501)65:9<2091::aid-cncr2820650934>3.0.co;2-m · Cited by 100
Second primary cancers after sporadic and familial colorectal cancer.
Hemminki, K., Li, X., & Dong, C. (2001) · PubMed · Cited by 92
Is surveillance of the small bowel indicated for Lynch syndrome families?
ten Kate, G. L., Kleibeuker, J. H., Nagengast, F. M., Craanen, M. E., Cats, A., Menko, F. H., & Vasen, H. F. A. (2007) · Gut · doi:10.1136/gut.2006.118299 · Cited by 86
Myrhøj, T., Andersen, M.-B., & Bernstein, I. (2008) · Familial Cancer · doi:10.1007/s10689-008-9193-9 · Cited by 82
Prostate cancer is part of the hereditary non‐polyposis colorectal cancer (HNPCC) tumor spectrum
Soravia, C., van der Klift, H. M., Bründler, M., Blouin, J., Wijnen, J., Hutter, P., Fodde, R., & DeLozier-Blanchet, C. D. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20106 · Cited by 67
A Population-Based Analysis of Second Primary Cancers After Irradiation for Rectal Cancer
Kendal, W. S., & Nicholas, G. A. (2007) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000258084.55036.9e · Cited by 64
Evidence for breast cancer as an integral part of lynch syndrome
Bürki, N., Gautier, L., Kovac, M. B., Marra, G., Buser, M. W., Mueller, H., & Heinimann, K. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20935 · Cited by 61
Sijmons, R. H., Hofstra, R. M. W., Hollema, H., Mensink, R. G. J., van der Hout, A. H., Hoekstra, H. J., Kleibeuker, J. H., Molenaar, W. M., Wijnen, J., Fodde, R., et al. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999<::aid-gcc1042>3.0.co;2-t · Cited by 44
Bonadona, V., Bonaïti, B., Olschwang, S., Grandjouan, S., Wang, Q., Bonaïti‐Pellié, C., & Lasset, C. (2011) · HAL · Cited by 36
Arana, V. M., del Pino, Y. B., Castro, C. G., González-Aguilera, J. J., Fernández‐Peralta, A. M., & Hermoso, F. G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf163 · Cited by 23
Huang, R.-L., Chao, C., Ding, D., Yu, C., Chang, C., Lai, H.-C., Yu, M., Liu, H.-S., & Chu, T. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.01.003 · Cited by 16
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Møller, P., Seppälä, T. T., Bernstein, I., Holinski-Feder, E., Sala, P., Gareth Evans, D., Lindblom, A., Macrae, F., Blanco, I., Sijmons, R. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314057 · Cited by 576
Self-citationClinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., McGuire, V., Ladabaum, U., Kobayashi, Y., Lincoln, S. E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6607 · Cited by 485
InSiGHT, O. B. O., Thompson, B. A., Spurdle, A. B., Plazzer, J.-P., Greenblatt, M. S., Akagi, K., Al-Mulla, F., Bapat, B., Bernstein, I., Capellá, G., et al. (2014) · Nature Genetics · doi:10.1038/ng.2854 · Cited by 467
Self-citationPrevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer
Grant, R. C., Selander, I., Connor, A. A., Selvarajah, S., Borgida, A., Briollais, L., Petersen, G. M., Lerner-Ellis, J., Holter, S., & Gallinger, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.042 · Cited by 299
Self-citation
Metadata
- Authors
- Win, A. K., Lindor, N. M., Young, J. P., Macrae, F. A., Young, G. P., Williamson, E., Parry, S., Goldblatt, J., Lipton, L., Winship, I., Leggett, B., Tucker, K. M., Giles, G. G., Buchanan, D. D., Clendenning, M., Rosty, C., Arnold, J., Levine, A. J., Haile, R. W., Gallinger, S., Marchand, L. L., Newcomb, P. A., Hopper, J. L., & Jenkins, M. A.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-28
- Volume
- 104
- Issue
- 18
- Pages
- 1363-1372
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2137641368
- Cited by
- 254
- References
- 48
- FWCI
- 14.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.